Suppr超能文献

肝脏的微尺度体外生理模型:药物代谢和酶诱导的预测性筛选

A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction.

作者信息

Sivaraman A, Leach J K, Townsend S, Iida T, Hogan B J, Stolz D B, Fry R, Samson L D, Tannenbaum S R, Griffith L G

机构信息

Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

出版信息

Curr Drug Metab. 2005 Dec;6(6):569-91. doi: 10.2174/138920005774832632.

Abstract

In vitro models of the liver using isolated primary hepatocytes have been used as screens for measuring the metabolism, toxicity and efficacy of xenobiotics, for studying hepatocyte proliferation, and as bioartificial liver support systems. Yet, primary isolated hepatocytes rapidly lose liver specific functions when maintained under standard in vitro cell culture conditions. Many modifications to conventional culture methods have been developed to foster retention of hepatocyte function. Still, not all of the important functions -- especially the biotransformation functions of the liver -- can as yet be replicated at desired levels, prompting continued development of new culture systems. In the first part of this article, we review primary hepatocyte in vitro systems used in metabolism and enzyme induction studies. We then describe a scalable microreactor system that fosters development of 3D-perfused micro-tissue units and show that primary rat cells cultured in this system are substantially closer to native liver compared to cells cultured by other in vitro methods, as assessed by a broad spectrum of gene expression, protein expression and biochemical activity metrics. These results provide a foundation for extension of this culture model to other applications in drug discovery -- as a model to study drug-drug interactions, as a model for the assessment of acute and chronic liver toxicity arising from exposure to drugs or environmental agents; and as a disease model for the study of viral hepatitis infection and cancer metastasis.

摘要

使用分离的原代肝细胞构建的肝脏体外模型,已被用作筛选异生物素的代谢、毒性和功效的工具,用于研究肝细胞增殖,以及作为生物人工肝支持系统。然而,原代分离的肝细胞在标准体外细胞培养条件下维持时,会迅速丧失肝脏特异性功能。人们已开发出许多对传统培养方法的改进措施,以促进肝细胞功能的保留。尽管如此,并非所有重要功能——尤其是肝脏的生物转化功能——目前都能在理想水平上得以复制,这促使人们持续研发新的培养系统。在本文的第一部分,我们回顾了用于代谢和酶诱导研究的原代肝细胞体外系统。接着,我们描述了一种可扩展的微反应器系统,该系统能促进三维灌注微组织单元的形成,并表明在该系统中培养的原代大鼠细胞,与通过其他体外方法培养的细胞相比,在基因表达、蛋白质表达和生化活性等广泛指标的评估下,与天然肝脏更为接近。这些结果为将这种培养模型扩展到药物发现的其他应用奠定了基础——作为研究药物相互作用的模型,作为评估因接触药物或环境因素而产生的急性和慢性肝毒性的模型;以及作为研究病毒性肝炎感染和癌症转移的疾病模型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验